ChromaDex Corporation
US ˙ NasdaqCM ˙ US1710774076
TEN SYMBOL NIE JEST JUŻ AKTYWNY

SecurityCDXC / ChromaDex Corporation
InstitutionNorthern Trust Corp
Latest Disclosed Ownership396,067 shares
Latest Disclosed Value $ 1,746,656
Northern Trust Corp reports 8.64% decrease in ownership of CDXC / ChromaDex Corporation

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 396,067 shares of ChromaDex Corporation (US:CDXC) valued at $1,746,656 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 433,536 shares of ChromaDex Corporation. This represents a change in shares of -8.64% during the quarter. The current value of the position is $3,117,047 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 396,067 -37,469 -8.64 1,747 -36.67 0.0000
2026-02-17 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 433,536 1,794 0.42 2,757 -31.55 0.0004
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 431,742 24,251 5.95 4,028 -31.39 0.0005
2025-08-13 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 407,491 9,422 2.37 5,872 113.80 0.0008
2025-05-13 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 398,069 -31,804 -7.40 2,747 20.44 0.0004
2025-02-14 2024-12-31 13F CHROMADEX COM NEW 171077407 429,873 52,170 13.81 2,280 65.46 0.0003
2024-11-13 2024-09-30 13F CHROMADEX COM 171077407 377,703 269,817 250.09 1,379 368.71 0.0002
2024-08-14 2024-06-30 13F CHROMADEX COM 171077407 107,886 7,568 7.54 295 -15.76 0.0000
2024-05-14 2024-03-31 13F CHROMADEX COM 171077407 100,318 6,234 6.63 349 160.45 0.0001
2024-02-13 2023-12-31 13F CHROMADEX COM 171077407 94,084 0 0.00 135 -2.19 0.0000
2023-11-13 2023-09-30 13F CHROMADEX COM 171077407 94,084 -630 -0.67 137 -7.43 0.0000
2023-08-11 2023-06-30 13F CHROMADEX COM 171077407 94,714 -265 -0.28 149 2.07 0.0000
2023-05-15 2023-03-31 13F CHROMADEX COM 171077407 94,979 4,642 5.14 145 -3.97 0.0000
2023-02-13 2022-12-31 13F CHROMADEX COM 171077407 90,337 0 0.00 152 36.04 0.0000
2022-11-14 2022-09-30 13F CHROMADEX COM 171077407 90,337 0 0.00 111 -26.49 0.0000
2022-08-12 2022-06-30 13F CHROMADEX COM 171077407 90,337 -338,480 -78.93 151 -85.67 0.0000
2022-05-13 2022-03-31 13F CHROMADEX COM 171077407 428,817 -20,645 -4.59 1,054 -37.26 0.0002
2022-02-08 2021-12-31 13F CHROMADEX COM 171077407 449,462 3,033 0.68 1,680 -39.98 0.0003
2021-11-15 2021-09-30 13F CHROMADEX COM 171077407 446,429 -27,340 -5.77 2,799 -40.09 0.0005
2021-08-13 2021-06-30 13F CHROMADEX COM NEW 171077407 473,769 29,635 6.67 4,672 12.66 0.0008
2021-05-12 2021-03-31 13F CHROMADEX COM NEW 171077407 444,134 -33,388 -6.99 4,147 80.93 0.0008
2021-02-11 2020-12-31 13F CHROMADEX COM NEW 171077407 477,522 -7,536 -1.55 2,292 17.84 0.0004
2020-11-16 2020-09-30 13F CHROMADEX COM NEW 171077407 485,058 -20,285 -4.01 1,945 -16.13 0.0004
2020-08-14 2020-06-30 13F CHROMADEX COM 171077407 505,343 12,542 2.55 2,319 44.31 0.0005
2020-05-14 2020-03-31 13F CHROMADEX COM NEW 171077407 492,801 28,288 6.09 1,607 -19.73 0.0005
2020-02-14 2019-12-31 13F CHROMADEX COM 171077407 464,513 18,720 4.20 2,002 14.07 0.0004
2019-11-13 2019-09-30 13F CHROMADEX COM 171077407 445,793 28,882 6.93 1,755 -9.49 0.0004
2019-08-13 2019-06-30 13F CHROMADEX COM 171077407 416,911 3,090 0.75 1,939 11.82 0.0005
2019-05-13 2019-03-31 13F CHROMADEX COM 171077407 413,821 2,385 0.58 1,734 22.80 0.0004
2019-02-12 2018-12-31 13F CHROMADEX COM 171077407 411,436 5,009 1.23 1,412 -18.99 0.0004
2018-11-14 2018-09-30 13F CHROMADEX COM 171077407 406,427 287,127 240.68 1,743 293.45 0.0004
2018-09-18 2018-06-30 13F/A-1 CHROMADEX COM 171077407 119,300 63,398 113.41 443 88.51 0.0001
2018-08-14 2018-06-30 13F CHROMADEX COM 171077407 119,300 63,398 443
2018-05-09 2018-03-31 13F CHROMADEX COM 171077407 55,902 14,297 34.36 235 -4.08 0.0001
2018-02-14 2017-12-31 13F CHROMADEX COM 171077407 41,605 950 2.34 245 40.00 0.0001
2017-11-13 2017-09-30 13F CHROMADEX COM 171077407 40,655 -2,233 -5.21 175 6.71 0.0000
2017-08-11 2017-06-30 13F CHROMADEX COM 171077407 42,888 -248,311 -85.27 164 -79.05 0.0000
2017-05-12 2017-03-31 13F CHROMADEX COM 171077407 291,199 -1,080 -0.37 783 -19.03 0.0002
2017-02-13 2016-12-31 13F CHROMADEX COM 171077407 292,279 694 0.24 967 11.28 0.0003
2016-11-09 2016-09-30 13F CHROMADEX COM 171077407 291,585 -941 -0.32 869 -28.24 0.0003
2016-08-12 2016-06-30 13F CHROMADEX COM 171077407 292,526 292,526 1,211 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.